Processing of the papain precursor. Purification of the zymogen and characterization of its mechanism of processing

The precursor of the cysteine protease papain has been expressed and secreted as propapain from insect cells infected with a recombinant baculovirus expressing a synthetic gene coding for prepropapain. This 39-kDa secreted propapain zymogen molecule is glycosylated and can be processed in vitro into...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 266; no. 32; pp. 21451 - 21457
Main Authors Vernet, T. (National Research Council of Canada, Montreal, Quebec, Canada), Khouri, H.E, Laflamme, P, Tessier, D.C, Musil, R, Gour-Salin, B.J, Storer, A.C, Thomas, D.Y
Format Journal Article
LanguageEnglish
Published Bethesda, MD American Society for Biochemistry and Molecular Biology 15.11.1991
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The precursor of the cysteine protease papain has been expressed and secreted as propapain from insect cells infected with a recombinant baculovirus expressing a synthetic gene coding for prepropapain. This 39-kDa secreted propapain zymogen molecule is glycosylated and can be processed in vitro into an enzymatically active authentic papain molecule of 24.5 kDa (Vernet, T., Tessier, D. C., Richardson, C., Laliberte, F., Khouri, H. E., Bell A. W., Storer, A. C., and Thomas, D. Y. (1990) J. Biol. Chem. 265, 16661-16666). Recombinant Propapain was stabilized with Hg2+ and purified to homogeneity using affinity chromatography, gel filtration, and ion-exchange chromatographic procedures. The maximum rate of Processing in vitro was achieved at approximately pH 4.0, at a temperature of 65 degrees C and under reducing conditions. Precursor processing is inhibited by a variety of reversible and irreversible cysteine protease inhibitors but not by specific inhibitors of serine, metallo or acid proteases. Replacement by site-directed mutagenesis of the active site cysteine with a serine at position 25 also prevents processing. The inhibitor 125I-N-(2S,3S)-3-trans-hydroxycarbonyloxiran-2-carbonyl-L-tyrosine benzyl ester covalently labeled the wild type papain precursor, but not the C25S mutant, indicating that the active site is accessible to the inhibitor and is in a native conformation within the Precursor. Based on biochemical and kinetic analyses of the activation and processing of propapain we have shown that the Papain precursor is capable of autoproteolytic cleavage (intramolecular). Once free papain is released processing can then occur in trans (intermolecular)
Bibliography:9177313
Q02
ISSN:0021-9258
1083-351X
DOI:10.1016/s0021-9258(18)54660-3